跳至主要内容
临床试验/NL-OMON37140
NL-OMON37140已完成2 期

Effect of high frequency transcranial magnetic stimulation on negative symptoms and cognitive functioning in schizophrenia: a combined treatment and neuroimaging study - Effect TMS on negative symptoms and cognitive functioning in schizophrenia

niversitair Medisch Centrum Groningen0 个研究点目标入组 32 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
32

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Patients included must have prominent negative symptoms and patients must have a negative subscore >= 15 on the Positive and Negative Syndrome Scale for Schizophrenia (PANSS). Only patients who are fully capable of making their own decision regarding participation in the research will be included.

排除标准

  • Exclusion criteria include rTMS and MRI contraindications (e.g. a personal or family history of epileptic seizures, history of brain surgery, intracerebral or pacemaker implants, inner ear prosthesis or other metal prosthetics/implants), neurological disorders, a head injury with loss of consciousness in the past, substance dependency within the previous 6 months, previous treatment with rTMS, severe behavioural disorders, inability to provide informed consent and claustrophobia. Female patients who are pregnant will be excluded.

研究者

相似试验